Targets of chimeric antigen receptor T-cell in breast cancer and the application progress / 肿瘤研究与临床
Cancer Research and Clinic
; (6): 73-77, 2023.
Article
in Zh
| WPRIM
| ID: wpr-996189
Responsible library:
WPRO
ABSTRACT
Breast cancer is the most common malignant tumor in women. It is particularly important to seek targeted therapy other than surgery, chemoradiotherapy, endocrine therapy. With the continuous exploration of tumor immunotherapy, more and more therapeutic targets have been discovered. This paper reviews therapeutic targets of chimeric antigen receptor T-cell (CAR-T) and the application in breast cancer.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Cancer Research and Clinic
Year:
2023
Type:
Article